Nutshell Therapeutics
宇道生物
Nutshell Therapeutics
Biotech/Healthcare
Nutshell Therapeutics has long focused on developing small-molecule drugs based on allosteric mechanisms. With a systematic portfolio of allostery-related technologies and deep scientific expertise, it is one of the few biotechnology companies globally that operates an allosteric drug discovery…
Latest round: Series C (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-09-15
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.